The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. The newly released data show people who once had a SARS-CoV-2 infection were much less likely than vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.

READ FULL ARTICLE AT SCIENCE MAG.COM

Other Headlines

Coronavirus

NEBRASKA AG: Docs Can Prescribe Ivermectin, Hydroxychloroquine

Nebraska’s attorney general says he won’t seek disciplinary action against doctors who prescribe off-label drugs to treat and prevent coronavirus infections, as long as they get informed consent from patients and don’t engage in misconduct. The office of Attorney General Doug Peterson released a legal opinion saying it didn’t see data to justify legal action against healthContinue reading NEBRASKA AG: Docs Can Prescribe Ivermectin, Hydroxychloroquine

More news about Coronavirus